Tyson's Angels Group

Tyson's Angels Group operates as an angel investment collective, channeling capital into nascent companies. The group specializes in providing seed-stage funding, with a strategic focus on disruptive innovations within the HealthTech and High Tech sectors. Their investment strategy involves identifying promising early-stage ventures across the United States, aiming to foster development through crucial initial financial backing.

Gian Dilawari co-founded Tyson's Angels Group in 2016, establishing the entity based on the insight that early-stage companies often require more than just capital. The group was formed to leverage experienced entrepreneurial and executive insights to guide emerging businesses through their critical formative periods. This approach stems from a recognition of the multifaceted support necessary for startup success.

The primary beneficiaries of Tyson's Angels Group's activities are early-stage startups seeking catalytic capital and strategic guidance to achieve transformative growth. The group's vision centers on empowering these ventures, particularly those developing cutting-edge solutions, to scale their operations and bring novel technologies and services to market. They aim to contribute to the innovation ecosystem by nurturing future industry leaders.